IBDEI02V ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,798,2)
 ;;=^5133686
 ;;^UTILITY(U,$J,358.3,799,0)
 ;;=L97.921^^3^32^56
 ;;^UTILITY(U,$J,358.3,799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,799,1,3,0)
 ;;=3^Non-prs chr ulc unsp prt of l low leg limited to brkdwn skin
 ;;^UTILITY(U,$J,358.3,799,1,4,0)
 ;;=4^L97.921
 ;;^UTILITY(U,$J,358.3,799,2)
 ;;=^5133680
 ;;^UTILITY(U,$J,358.3,800,0)
 ;;=L97.919^^3^32^62
 ;;^UTILITY(U,$J,358.3,800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,800,1,3,0)
 ;;=3^Non-prs chr ulc unsp prt of r low leg w unsp severity
 ;;^UTILITY(U,$J,358.3,800,1,4,0)
 ;;=4^L97.919
 ;;^UTILITY(U,$J,358.3,800,2)
 ;;=^5133688
 ;;^UTILITY(U,$J,358.3,801,0)
 ;;=L97.913^^3^32^63
 ;;^UTILITY(U,$J,358.3,801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,801,1,3,0)
 ;;=3^Non-prs chr ulc unsp prt of r low leg w necros muscle
 ;;^UTILITY(U,$J,358.3,801,1,4,0)
 ;;=4^L97.913
 ;;^UTILITY(U,$J,358.3,801,2)
 ;;=^5133683
 ;;^UTILITY(U,$J,358.3,802,0)
 ;;=L97.914^^3^32^64
 ;;^UTILITY(U,$J,358.3,802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,802,1,3,0)
 ;;=3^Non-prs chr ulc unsp prt of r low leg w necrosis of bone
 ;;^UTILITY(U,$J,358.3,802,1,4,0)
 ;;=4^L97.914
 ;;^UTILITY(U,$J,358.3,802,2)
 ;;=^5133685
 ;;^UTILITY(U,$J,358.3,803,0)
 ;;=L97.912^^3^32^65
 ;;^UTILITY(U,$J,358.3,803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,803,1,3,0)
 ;;=3^Non-prs chr ulc unsp prt of r low leg w fat layer exposed
 ;;^UTILITY(U,$J,358.3,803,1,4,0)
 ;;=4^L97.912
 ;;^UTILITY(U,$J,358.3,803,2)
 ;;=^5133681
 ;;^UTILITY(U,$J,358.3,804,0)
 ;;=L97.911^^3^32^61
 ;;^UTILITY(U,$J,358.3,804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,804,1,3,0)
 ;;=3^Non-prs chr ulc unsp prt of r low leg limited to brkdwn skin
 ;;^UTILITY(U,$J,358.3,804,1,4,0)
 ;;=4^L97.911
 ;;^UTILITY(U,$J,358.3,804,2)
 ;;=^5133679
 ;;^UTILITY(U,$J,358.3,805,0)
 ;;=L97.112^^3^32^102
 ;;^UTILITY(U,$J,358.3,805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,805,1,3,0)
 ;;=3^Non-prs chr ulcer of right thigh w fat layer exposed
 ;;^UTILITY(U,$J,358.3,805,1,4,0)
 ;;=4^L97.112
 ;;^UTILITY(U,$J,358.3,805,2)
 ;;=^5009486
 ;;^UTILITY(U,$J,358.3,806,0)
 ;;=L97.111^^3^32^101
 ;;^UTILITY(U,$J,358.3,806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,806,1,3,0)
 ;;=3^Non-prs chr ulcer of right thigh limited to brkdwn skin
 ;;^UTILITY(U,$J,358.3,806,1,4,0)
 ;;=4^L97.111
 ;;^UTILITY(U,$J,358.3,806,2)
 ;;=^5009485
 ;;^UTILITY(U,$J,358.3,807,0)
 ;;=L97.124^^3^32^83
 ;;^UTILITY(U,$J,358.3,807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,807,1,3,0)
 ;;=3^Non-prs chr ulcer of left thigh w necrosis of bone
 ;;^UTILITY(U,$J,358.3,807,1,4,0)
 ;;=4^L97.124
 ;;^UTILITY(U,$J,358.3,807,2)
 ;;=^5009493
 ;;^UTILITY(U,$J,358.3,808,0)
 ;;=L97.129^^3^32^85
 ;;^UTILITY(U,$J,358.3,808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,808,1,3,0)
 ;;=3^Non-prs chr ulcer of left thigh with unsp severity
 ;;^UTILITY(U,$J,358.3,808,1,4,0)
 ;;=4^L97.129
 ;;^UTILITY(U,$J,358.3,808,2)
 ;;=^5009494
 ;;^UTILITY(U,$J,358.3,809,0)
 ;;=L97.123^^3^32^84
 ;;^UTILITY(U,$J,358.3,809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,809,1,3,0)
 ;;=3^Non-prs chr ulcer of left thigh w necrosis of muscle
 ;;^UTILITY(U,$J,358.3,809,1,4,0)
 ;;=4^L97.123
 ;;^UTILITY(U,$J,358.3,809,2)
 ;;=^5009492
 ;;^UTILITY(U,$J,358.3,810,0)
 ;;=L97.113^^3^32^103
 ;;^UTILITY(U,$J,358.3,810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,810,1,3,0)
 ;;=3^Non-prs chr ulcer of right thigh w necrosis of muscle
 ;;^UTILITY(U,$J,358.3,810,1,4,0)
 ;;=4^L97.113
 ;;^UTILITY(U,$J,358.3,810,2)
 ;;=^5009487
 ;;^UTILITY(U,$J,358.3,811,0)
 ;;=L97.114^^3^32^104
 ;;^UTILITY(U,$J,358.3,811,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI02V
